Clinical Trials Directory

Trials / Completed

CompletedNCT06979960

The Effect of Face-to-Face and Online Training on Cancer Screening on Women's Knowledge, Attıtude and Shyness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Inonu University · Academic / Other
Sex
Female
Age
50 Years – 65 Years
Healthy volunteers
Accepted

Summary

Cancer is a large group of diseases that occur due to abnormal cell proliferation in almost all organs of the body. Cancer is the second leading cause of death in the world after cardiovascular diseases. The fact that cancer is a preventable disease reveals the importance of cancer screenings. Cancer screening aims to detect it in the early stages when the chance of treatment is high. Screening programs for breast cancer, cervical cancer and colorectal cancer are recommended by WHO. In order for these screening programs to achieve their goals, people within the scope of screening must participate in screening. However, there are many factors involved in participating in these screening programs. Even though health professionals direct people to screening programs, at this point people's knowledge, attitude and shyness levels affect their participation in screening programs. The research is planned to be experimentally pre-test-post-test, and the data will be collected before and after the training to be given face-to-face and online by the researcher. The results obtained as a result of the study will be taken into consideration by midwives in terms of the effect of the education given on cancer screenings on women's knowledge, attitude and shyness levels.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcancer screening educationIt will be carried out to examine the effect of the educational intervention given using the cancer screening training booklet on women's knowledge, attitude and shyness levels.

Timeline

Start date
2024-09-01
Primary completion
2024-12-31
Completion
2025-05-31
First posted
2025-05-20
Last updated
2026-03-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06979960. Inclusion in this directory is not an endorsement.